SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-036107
Filing Date
2019-06-11
Accepted
2019-06-11 16:47:36
Documents
2
Period of Report
2019-06-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1524
2 POA DOCUMENT poa.txt EX-24.3_859130 2989
  Complete submission text file 0001209191-19-036107.txt   5882
Mailing Address 1119 ST. PAUL STREET BALTIMORE MD 21202
Business Address
Nunn Jason Raleigh (Reporting) CIK: 0001444319 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35670 | Film No.: 19891447

Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 100 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Issuer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences